An Autoantibody Against Human DNA-Topoisomerase I Is a Novel Biomarker for Non-Small Cell Lung Cancer

Conclusions Our results indicate that the autoantibody can be used as a novel biomarker for the early diagnosis and prognosis of NSCLC.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research